Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think real billionaire potential here with $PULM (if one had enough shares, not suggesting I do)
Pulmatrix CEO Ted Raad commented,
“Pulmatrix roots were as a biodefense company and we were eager to leverage our experience and NasoCalm to help combat the rapidly emerging COVID-19 global pandemic.
Years ago we developed NasoCalm as a potential anti-infective biodefense medical countermeasure product. With results that show reduced viral progression and contagion in animal models, and demonstrated reductions of contagious bioaerosols and safety in humans, we believe NasoCalm may be a tool to manage the spread of COVID-19.
We look forward to partnering with Dr. Edwards and Sensory Cloud to seek rapid delivery of an Emergency Response Product to those most at risk of infection.”
https://www.oindpnews.com/2020/04/pulmatrix-licenses-nasocalm-to-sensory-cloud-for-an-otc-nasal-protection-product-against-covid-19/
$PULM !!!
Reminder: Robert Langer, David Edwards, Pulmatrix huge shoutout on a CV-19 Webinar on April 23, 2020 regarding NasoCalm.
Question starts at 16:00:
$PULM Reminder: Robert Langer, David Edwards, Pulmatrix huge shoutout on a CV-19 Webinar on April 23, 2020 regarding NasoCalm.
Question starts at 16:00:
$PULM Reminder: Robert Langer, David Edwards, Pulmatrix huge shoutout on a CV-19 Webinar on April 23, 2020 regarding NasoCalm.
Question starts at 16:00:
$MSMY -- short term market reaction; the full roar is coming.
The force is within us each. The tide is rising.
Those who stand in the way of humanity will soon know the force of creation.
$PULM
PreMarket Trades @ .003 -- intriguing...
$MSMY
1.96 close -- with 300K trade going through @ 1.97 immediately after. Tomorrow could be beast mode.
Day's not over... and things are setting up extremely bullish.
Mick, big things about to happen here. $PULM
$PULM
Tick Tock Tick Tock
$PULM
Tick Tock Tick Tock
$PULM
$MSMY -- let's get it!
J&J Vaccine Webcast Starting Tomorrow
Virtual Shareholder Meeting - 6/17 11:30 EST
If you base your perspective off the fact that iSPERSE was co-developed by Robert Langer, David Edwards, Alexander Klibanov -- and then look at the current level of hype around Robert Langer's other company, Moderna -- and then overlay the fact that we are involved with $JNJ & $CIPLA. With fast track designations and big partnerships goals & targets.
While in parallel starting a partnership with a shell company in Sensory-Cloud (who David Edwards founded & Jessica KG leads) featuring NasoCalm, a DARPA funded anti-contagion for all diseases -- & potential vehicle to turn other drugs (such as Resmedivir) into an inhaled version, safer and more effective... with both civilian and military benefits...
Then you know what is coming is beyond anything being talked about in the day to day price action.
https://finance.yahoo.com/quote/PULM/profile/
$PULM
It feels as if our time has arrived. Timing syncing up.
$PULM
Seems to me they are advertising this as apart of their strategic advancement towards brand design / custom white label manufacturing.
Good sign!
Aye pennyland calls.
5.3million on the bid @ .0017
$MSMY
Like a thief in the night, it will come
$PULM
Don't underestimate Pulmatrix's emphasis on their roots as a bio-defense company in their NasoCalm PR. Not coincidental they are highlighting such.
Some really huge statements/facts right in front of our eye.
"Pathogen Independence"
"Rapid Delivery of an Emergency Response"
"Ease of Inhalation & Climate Tolerance"
"Civilian & Military Personel"
"Disrupt the induction of an infection"
$5.7M DARPA Study back in 2010
MIT Labs
Harvard Labs
$PULM
$PULM For sure before 6/17 (shareholder meeting) -- yet due any day now. Sensory-cloud (NasoCalm partner led by former Pulmatrix alumni and Harvard BioEngineer David Edwards [student/co-founder of Pulmatrix with Robert Langer]) just updated research on their website as of Friday. Company has been silent on the matter for 6 weeks, anyday now.
David Edwards also is involved with Bill & Melinda Gates MEND initiative.
https://sensory-cloud.com/
Speculation that J&J Road to Vaccine series last episode today may be a trigger point for J&J news. Anyday yet could need a week or 2 max potentially. Larger timelines in play, imo. National/global news and reach potential. Think Moderna type of press, without the nonsense.
$PULM
$PULM - FDA Fast Track News coming on NasoCalm. J&J Partnership for CV-19 Therapeutics/Vaccine (PUR1800?). New TB needleless Vaccine. New Best in Class $5B Market Pulmazole with CIPLA (already fast-tracked).
Supernova alert.
$PULM - 1.66 -- <big time potential> -- news imminent will rocketship. Timing is right.
G'Morning Augusta & Orion Friends
Point is the math and potential supports super large share price valuations.
$PULM
PT: $69,350 --
That's a 4,127,976% price increase, lulz.
$PULM
Historic Opportunity Here $PULM - $1.68
G'Evening -- some very interesting numbers shown on post before - $PULM may be a historic investment opportunity right here..
$MSMY Just getting started -- great CEO & Company. Cash flow positive.
Some staggering simple numbers to show the widespread potential of NasoCalm's global royalty structure -- given its potential as an OTC anti-contagion solution to any pandemic disease in the world. Military-research anti-contagion bio-defense company designed for use of civilian and army. This is the real deal.
-- World Population: 7.6Billion People
-- Days in Year 365
--Days x Population = 2.77 Trillion single day dosages the world would require for full coverage
-- NasoCalm Effective Duration: ~6Hours (so 1 per day may be a reasonable estimate)
If Pulmatrix made only $0.10 per dose (seems very low yet just for perspective) -- then that would equate to $277B of revenue/earnings...
For shits an giggles-- 10x multiple on such earnings is a casual stock price of $69,350 on 40million shares.
I know those numbers likely would never be hit, but even a fraction of that with what looks to be the recipe for a historic investment opportunity.
And then there is everything else.
$PULM
$PULM -- Billionaire Type of Return on Investment?
Some staggering simple numbers to show the widespread potential of NasoCalm's global royalty structure -- given its potential as an OTC anti-contagion solution to any pandemic disease in the world. Military-research anti-contagion bio-defense company designed for use of civilian and army. This is the real deal.
-- World Population: 7.6Billion People
-- Days in Year 365
--Days x Population = 2.77 Trillion single day dosages the world would require for full coverage
-- NasoCalm Effective Duration: ~6Hours (so 1 per day may be a reasonable estimate)
If Pulmatrix made only $0.10 per dose (seems very low yet just for perspective) -- then that would equate to $277B of revenue/earnings...
For shits an giggles-- 10x multiple on such earnings is a casual stock price of $69,350 on 40million shares.
I know those numbers likely would never be hit, but even a fraction of that with what looks to be the recipe for a historic investment opportunity.
And then there is everything else.
$PULM
Nice day so far in $MSMY my good friend, Mick. More to come it looks like, just getting started here!